Switzerland· 39001039
Parlodel, Tabletten
A bromocriptine product containing bromocriptinum, registered in Switzerland by Sandoz Pharmaceuticals AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Bromocriptine is registered in 9 of 19 countries.
Countries holding a registration under ATC G02CB01 (bromocriptine), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 7 of them publish a price we can compare per daily dose
Bromocriptine · ATC G02CB01
9 / 19 countries
- Czechiaprice
- Finlandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of bromocriptine costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.54 in Italy to $3.22 in United States — a ×5.9 gap.
- Switzerland: $2.09 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Bromocriptine · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- US United States$3.22 (acquisition cost)
- CH Switzerland$2.09
- IT Italy$0.54
The record
At a glance
Swissmedic (Switzerland)- Active substance
- bromocriptinum
- Manufacturer
- Sandoz Pharmaceuticals AG
- Country
- Switzerland (CH)
- ATC code
- G02CB01
- ATC class
- Bromocriptine
- Defined daily dose
- 5 mg, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680390010396100 StkCHF 65.4
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
92 interactions on record for bromocriptine.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bromocriptine · interactions on record
92 records
- 3 severe
- 87 moderate
- 2 minor
Most severe, free to view
- IsomethepteneA03AX10severe
- LorcaserinA08AA11severe
- PhenylpropanolaminA08AA13severe
- LansoprazoleA02BC03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bromocriptine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBromocriptine 2.5mg tabletsTeva UK Ltd
- United StatesBromocriptine mesylateREMEDYREPACK INC.
- CzechiaMEDOCRIPTINEMedochemie Ltd., Limassol
- SwedenParlodel 2,5 mg TablettOrifarm AB
- PolandBromocornFarmaceutyczna Spółdzielnia Pracy FILOFARM
- NorwayParlodelMeda
- FinlandParlodelOrifarm Oy
- NetherlandsParlodel 2,5 mg, tablettenMedcor Pharmaceuticals B.V.
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Belgium · Parlodel
- Bulgaria · Бромокриптин Медокеми
- Cyprus · Medocriptine, Pirodal
- Czechia · Medocriptine
- Germany · Pravidel
- Estonia · Bromocriptin Richter
- Spain · Parlodel
- France · Parlodel
- United Kingdom (Northern Ireland) · Bromocriptine, Bromocriptine Brown & Burk Uk
- Hungary · Bromocriptin Richter
- Italy · Parlodel
- Lithuania · Bromocriptin Richter
- Luxembourg · Pravidel
- Latvia · Bromocriptin Richter
- Malta · Medocriptine
- Netherlands · Parlodel
- Norway · Parlodel
- Poland · Bromocorn
- Portugal · Bromocriptina Generis, Parlodel
- Romania · Brocriptin
- Sweden · Pravidel
- Slovakia · Medocriptine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c561a82f-7070-4ae0-83ca-3d86fbf7b26a GET /v1/drugs/c561a82f-7070-4ae0-83ca-3d86fbf7b26a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "bromocriptinum 2.5 mg",
"valid_from": "1976-03-15",
"limitations": null,
"galenic_form": "Tabl 2.5 mg",
"therapeutic_area": null,
"sl_inclusion_date": "1976-03-15",
"self_retention_pct": 10
}See everything about bromocriptine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.